MANILA, Philippines — In a joint statement, the Philippine Pediatric Society (PPS) and the Pediatric Infectious Disease Society of the Philippines (PIDSP) emphasized adherence to key strategies recommended by the DOH: vector control and early consultation.
These strategies are summarized as the “4S Against Dengue,” which are: Searching and destroying mosquito larvae sites in surroundings; Self-protection measures such as wearing protective clothing and applying mosquito repellant; Seeking early medical consultation upon observation of fever and rashes that persist for 48 hours; and Saying no to indiscriminate fogging, which should only be implemented during outbreaks.
Noting that dengue has no specific anti-viral treatment, early recognition and prompt access to medical care are essential to lowering the mortality rate from the disease, according to the doctors.
While the organizations recognize vaccination as an integral component in the global strategy for dengue prevention and control, “it is not currently recommended as part of outbreak response,” emphasized PIDSP president Dr. Anna Lisa Ong-Lim.
The vaccine “is for future protection for those who were diagnosed or have been known to have dengue or tested positive for dengue antibody,” added PPS president Dr. Salvacion Gatchalian. “With the availability of the vaccine, parents and patients will be informed of the benefits and risks, and an informed decision can be made and that its administration be an informed choice,” she said.
Latest DOH data indicate 146,062 dengue cases recorded in the country from January to July 20 this year, a 98 percent increase in cases compared to the same period in 2018. To date, a total of 622 deaths due to dengue has been reported. – Philippine Pediatric Society and the Pediatric Infectious Disease Society of the Philippines